Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery

Acta Obstetricia et Gynecologica Scandinavica

Volumn 80, Issue 6, 2001, Pages 546-551

  Kekki, M ^a   Kurki, T ^a   Karkkainen T ^b   Hiilesmaa, V ^a   Paavonen, J ^a   Rutanen, E M ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Medix Biochemica ^*  (Finland)

Author keywords

Phosphorylated IGFBP 1; Preterm delivery; Preterm uterine contractions

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ARTICLE; CONTROLLED STUDY; DECIDUA; FEMALE; FETUS MEMBRANE; FINLAND; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; PREDICTION; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RISK FACTOR; UTERINE CERVIX MUCUS; UTERUS CONTRACTION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CERVIX UTERI; CONFIDENCE INTERVALS; FEMALE; FINLAND; GESTATIONAL AGE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; LOGISTIC MODELS; OBSTETRIC LABOR, PREMATURE; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; UTERINE CONTRACTION;

EID: 0035016646     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2001.080006546.x     Document Type: Article

References (18)

1. Primary structure of human insulin-like growth factor binding protein/placental protein 12 and tissue expression of its mRNA
2. Radioimmunoassay of placental protein 12: Levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women and patients with trophoblastic disease
3. Gestational age-dependent expression of insulin-like growth factor binding protein-1 (IGFBP-1) phosphoforms in human extraamniotic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy
4. Phosphorylated isoforms of insulin-like growth factor binding protein-1 in the cervix as a predictor of cervical ripeness
5. Monoclonal antibodies to the 27-34K insulin-like growth factor binding protein
6. Evaluation of rapid strip test for insulin-like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes
7. Insulin-like growth factor binding protein-1 in cervix as a marker of infectious complications in pregnant women with bacterial vaginosis
8. Infections in pregnancy
9. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery
10. Fetal fibronectin in patients at increased risk for preterm birth
11. Neutrophil attractant/activating peptide-1/interleukin-8: Association with histologic chorioamnionitis, preterm delivery and bioactive amniotic fluid leukoattractants
12. Detection of tumor necrosis factor-α, interleukin-6 and fetal fibronectin in the lower genital tract during pregnancy: Relation to outcome
13. Use of fetal fibronectin in clinical practice
14. A single cervical fetal fibronectin screening test in a population at low risk for preterm delivery: An improvement on clinical indicators?
15. Fetal fibronectin detection for prediction of preterm birth in low risk women
16. Coitus during pregnancy is not related to bacterial vaginosis or preterm birth
17. Markers of the risk for preterm delivery
18. Measurement of insulin-like growth factor binding protein-1 in cervical/vaginal secretions: Comparison with the ROM-check membrane immunoassay in the diagnosis of ruptured fetal membranes